Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

Daniele Santini, Anna Maria Frezza, Olga Venditti, Salvatore Intagliata, Emanuela Dell'aquila, Francesco Guida, Bruno Vincenzi, Giuseppe Tonini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)473-474
Number of pages2
JournalExpert Opinion on Therapeutic Targets
Issue number4
Publication statusPublished - Apr 2013

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this